You are here
Home > MedlinePlus

MedlinePlus is a service of the National Library of Medicine (NLM), the world's largest medical library, which is part of the National Institutes of Health (NIH). It was built as an online health information resource for patients and their families and friends.

MedlinePlus presents high-quality, easy to understand, relevant health and wellness information that is trusted.

Alphabetical Listings

a b c d e f g h i j k l m
n o p q r s t u v w x y z

MedlinePlus at a Glance

  • Offers information on health topics, human genetics, medical tests, medications, dietary supplements, and healthy recipes.
  • Sourced from more than 1,600 selected organizations.
  • Provides 40,000 links to authoritative health information in English and 18,000 links to information in Spanish.
  • In 2018, 277 million users viewed MedlinePlus more than 700 million times.

Mesothelioma

The tissue that lines your lungs, stomach, heart, and other organs is called mesothelium. Mesothelioma, also known as malignant mesothelioma, is cancer of that tissue. It usually starts in the lungs, but can also start in the abdomen or other organs.

Malignant mesothelioma is rare but serious. Most people who get it have worked or lived in places where they inhaled or swallowed asbestos particles. After being exposed to asbestos, it usually takes a long time for the disease to form.

Symptoms include:

  • Trouble breathing
  • Cough
  • Pain under the rib cage
  • Pain, swelling, or lumps in the abdomen
  • Weight loss for no known reason
  • Blood clots
  • Constipation
  • Fatigue

Sometimes it is hard to tell the difference between malignant mesothelioma and lung cancer. To find out if you have mesothelioma, your health care provider will likely use a physical exam, imaging tests, and a biopsy.

Malignant mesothelioma is often found when it is advanced. This makes it harder to treat. Treatment options may include:

  • Surgery
  • Radiation therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells

NIH: National Cancer Institute




thpxl